Rapid development of severe interstitial pneumonia caused by epoprostenol in a patient with primary pulmonary hypertension

Anesthesia and Analgesia

Volumn 99, Issue 4, 2004, Pages 1205-1207

  Morimatsu, Hiroshi ^a   Goto, Keiji ^a   Matsusaki, Takashi ^a   Katayama, Hiroshi ^a   Matsubara, Hiromi ^a   Ohe, Tohru ^a   Morita, Kiyoshi ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METHYLPREDNISOLONE; NITRIC OXIDE; PREDNISOLONE; PROSTACYCLIN; PROSTAGLANDIN E; STEROID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOMEGALY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG LYMPH LEVEL; ELECTROCARDIOGRAPHY; FEMALE; HEART RIGHT VENTRICLE HYPERTROPHY; HEMOSTASIS; HUMAN; INTERSTITIAL PNEUMONIA; LABORATORY TEST; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STOMACH HEMORRHAGE; SWAN GANZ CATHETER; THORAX RADIOGRAPHY;

ADULT; ALPROSTADIL; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES, INTERSTITIAL; OXYGEN INHALATION THERAPY; PLATELET AGGREGATION INHIBITORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4644326862     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000130615.28893.52     Document Type: Article

References (8)

1. Peacock AJ. Treatment of pulmonary hypertension. BMJ 2003; 326:835-6.
2. Archer S, Rich S. Primary pulmonary hypertension. Circulation 2000;102:2781-91.
3. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-44.
4. Barst RJ, Rubin LJ, McGoon MD, et al. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994;121:409-15.
5. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334:296-301.
6. McLaughlin W, Genthner DE, Panella MM, et al. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338:273-7.
7. Ahearn GS, Selim MA, Tapson VF. Severe erythroderma as a complication of continuous epoprostenol therapy. Chest 2002; 122:378-80.
8. Kesten S, Dainauskas J, McLaughlin V, et al. Development of nonspecific interstitial pneumonitis associated with long-term treatment of primary pulmonary hypertension with prostacyclin. Chest 1999;116:566-9.